Lupisera D Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg and Serratiopeptidase 10 mg. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain, inflammation, and fever. Serratiopeptidase, a proteolytic enzyme, enhances the anti-inflammatory effect by breaking down inflammatory mediators and promoting the resolution of edema and tissue repair. This synergistic formulation is indicated for the management of acute and chronic inflammatory conditions such as musculoskeletal disorders, postoperative pain, rheumatoid arthritis, osteoarthritis, and soft tissue injuries. Lupisera D Tablet provides effective relief from pain, swelling, and stiffness, improving patient mobility and quality of life. It should be used under medical supervision, especially in patients with a history of gastrointestinal ulcers, bleeding disorders, or renal impairment. Common side effects may include gastrointestinal discomfort, nausea, or allergic reactions. Caution is advised during pregnancy and lactation. Regular monitoring is recommended during prolonged therapy to detect potential adverse effects. Lupisera D Tablet offers a balanced approach to inflammation control and pain management through its dual-action mechanism.